PROTAC-Mediated Degradation of mHTT Aggregates Attenuates Neurotoxicity in Cellular and R6/2 Mouse Models of Huntington's Disease. [PDF]
Lu PC +8 more
europepmc +1 more source
A machine learning-based pharmacokinetics predictor (EGFR-PROPK) for EGFR-targeting PROTACs. [PDF]
Zhang R +6 more
europepmc +1 more source
Data-Driven Design of PROTAC Linkers to Improve PROTAC Cell Membrane Permeability. [PDF]
Murakami Y +7 more
europepmc +1 more source
Prospects and advances of PROTAC in the treatment of hematologic malignancies. [PDF]
Wang X, Zhang M, Mei H.
europepmc +1 more source
Mechanisms and Design Principles of Proteolysis-Targeting Chimeras and Their Emerging Applications. [PDF]
Knoll N, Neamati N, Üren A.
europepmc +1 more source
PROTAC-mediated multi-target protein degradation in Alzheimer's disease: mechanistic insights, therapeutic applications, and translational challenges. [PDF]
Wang B +7 more
europepmc +1 more source
PROTAC-Mediated Targeted Degradation of MDM2 Induces Tumor-Suppressive Signaling in Osteosarcoma Cells. [PDF]
Kim Y +12 more
europepmc +1 more source
AI-Based Prediction of PROTAC- and Molecular Glue-Mediated Ternary Complexes: A Comparative Evaluation of AlphaFold 3 and Boltz-2. [PDF]
Riepenhausen L +3 more
europepmc +1 more source
Targeting BCL-xL in Myeloid Malignancies: From Inhibitors to PROTAC. [PDF]
Cilloni D, Ferrando A, Frassoni F.
europepmc +1 more source
Unveiling BCL-xL-specific PROTAC efficiency and dissociation pathways using native mass spectrometry. [PDF]
Gadallah MI +8 more
europepmc +1 more source

